RT Journal Article
SR Electronic
T1 Firearm Purchasing and Firearm Violence in the First Months of the Coronavirus Pandemic in the United States
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.02.20145508
DO 10.1101/2020.07.02.20145508
A1 Julia P. Schleimer
A1 Christopher D. McCort
A1 Veronica A. Pear
A1 Aaron Shev
A1 Elizabeth Tomsich
A1 Rameesha Asif-Sattar
A1 Shani Buggs
A1 Hannah S. Laqueur
A1 Garen J. Wintemute
YR 2020
UL http://medrxiv.org/content/early/2020/07/04/2020.07.02.20145508.abstract
AB Importance Firearm violence is a significant public health and safety problem in the United States. A surge in firearm purchases following the onset of the coronavirus pandemic may increase rates of firearm violence.Objective To estimate the association between changes in firearm purchasing and interpersonal firearm violence during the coronavirus pandemic.Design Cross-sectional time series study. We estimate the difference between observed rates of firearm purchases and those predicted by seasonal autoregressive integrated moving average models. Using negative binomial models, we then estimate the association between excess firearm purchases and rates of interpersonal firearm violence within states, controlling for confounders.Setting The 48 contiguous states and the District of Columbia. Hawaii and Alaska are excluded due to missing or incomplete data.Exposure The difference between observed and expected rates of firearm purchases in March through May 2020, approximated by National Instant Criminal Background Check System records.Main Outcome and Measure Fatal and nonfatal injuries from interpersonal firearm violence, recorded in the Gun Violence Archive.Results We estimate that there were 2.1 million excess firearm purchases from March through May 2020—a 64.3% increase over expected volume, and an increase of 644.4 excess purchases per 100,000 population. We estimate a relative rate of death and injury from firearm violence of 1.015 (95% Confidence Interval (CI): 1.005 to 1.025) for every 100 excess purchases per 100,000, in models that incorporate variation in purchasing across states and control for effects of the pandemic common to all states. This reflects an increase of 776 fatal and nonfatal injuries (95% CI: 216 to 1,335) over the number expected had no increase in purchasing occurred.Conclusions and Relevance We find a significant increase in firearm violence in the United States associated with the coronavirus pandemic-related surge in firearm purchasing. Our findings are consistent with existing research. Firearm violence prevention strategies may be particularly important during the pandemic.Question Is the coronavirus-related surge in firearm purchasing associated with changes in rates of interpersonal firearm violence?Findings This cross-sectional time series study suggests the recent increase in firearm purchases—an estimated 2.1 million excess purchases nationally between March and May 2020—is associated with a statistically significant increase in firearm violence. We estimate an increase of 776 fatal and nonfatal injuries (95% CI: 216 to 1,335) in the US over the number expected for those months had there been no increase in purchasing.Meaning During the coronavirus pandemic, an acute increase in firearm access is associated with an increase in firearm violence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSupport for this research was provided by the Joyce Foundation (grant no. 42400), the Heising-Simons Foundation (grant no. 2019-1728), and the University of California Firearm Violence Research Center. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the University of California, Davis Institutional Review Board (IRB number 1609326-1).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available. Links and references are provided in the supplement.